Conferences  >  Medicine & Healthcare  >  Translational Medicine, Clinical Trials

CRUK, ESMO, Unicancer

The Molecular Analysis for Precision Oncology Congress 2025 will take place from 15 to 16 September in Paris, France, uniting leading experts in oncology, molecular diagnostics, and precision medicine for dynamic discussions and collaboration, with a focus on decoding the molecular bases of cancer to enable precision oncology. The congress will delve into transformative topics shaping cancer research, including cancer prevention, interception, epigenetics, metastasis, and cancer evolution, offering a deeper understanding of mechanisms driving progression and resistance.

MAP Congress Team;     Phone: [+41 (0)91 973 19 47];     Email: map@esmo.org

molecular oncology, precision medicine, molecular diagnostics, cancer prevention, cancer interception, epigenetics, metastasis, cancer evolution, cancer resistance, artificial intelligence in oncology, cancer immunology, immunotherapy, aging and senescence, microbiome and cancer, metabolism dysregulation, therapeutic vulnerabilities, cancer research, oncology collaboration, AI-driven diagnostics, innovative cancer treatments

Oncology,    Pharmacogenomics, Personalized Medicine

Virtue Insight

Clinical Trials Series 2025 emerges as a timely and essential platform to explore the future of clinical research and innovation. Bringing together leaders from across the clinical trials ecosystem—including sponsors, CROs, regulatory bodies, academic researchers, technology providers, and patient advocates—this summit offers a collaborative space to examine the latest developments, share strategic insights, and drive forward-thinking discussions.

Email: Kavitha@virtueinsight.co.in

clinical trials, clinical research, CROs, Clinical studies, drugs, regulatory, patients, clinical R&D, Medical Affairs, Regulatory Affairs, Quality control, pharma, pharmaceuticals

The European Association for Cancer Research (EACR), with support from The Organisation of European Cancer Institutes (OECI)

This virtual event will explore how meaningful involvement of cancer advocates throughout the research process can lead to impactful cancer research. We will highlight practical examples and offer insights into how researchers, clinicians, and patient advocates can work together to bridge gaps between science and cancer care. Participants will better understand the opportunities and challenges in shaping a collaborative research culture to advance research and improve cancer care.

Chris Iliffe (Conference Officer);     Phone: [N/A];     Email: christopher.iliffe@eacr.org

cancer research, oncology, cancer patients, patient perspective, patient advocacy, cancer care, cancer treatment, patient quality of life, cancer symptom management, cancer therapy side effects, innovative therapy development, collaborative research

Oncology,    Healthcare Technologies

The European Association for Cancer Research (EACR)

This conference will explore the fundamental mechanisms controlling cancer cell plasticity at multiple biological levels including the epigenome, transcriptome, metabolome, and cellular microenvironment. Our panel of expert speakers will also discuss innovative approaches to target cell plasticity using novel pharmacological interventions that aim to prevent or reverse the adaptive mechanisms cancer cells use to circumvent conventional therapies.

Chris Iliffe (Conference Officer);     Phone: [N/A];     Email: christopher.iliffe@eacr.org

cancer research, oncology, cancer cell biology, cancer cell plasticity, cancer epigenetics, cellular microenvironment, tumour microenvironment, tumour heterogeneity, cancer transcriptomics, metabolic reprogramming in cancer, phenotypic changes in cancer, cancer progression, cancer therapy resistance, virtual academic conference

Oncology,    Molecular Biology

IIT (BHU), Varanasi

Drug Discovery and Translational Healthcare 2025 (DDTH 2025) will be held on December 2-3, 2025, at the School of Biochemical Engineering, Indian Institute of Technology (BHU) Varanasi, India, in collaboration with two prestigious societies, Bioinformatics and Drug Discovery Society (BDDS)" and "Biotechnology Society of India (BSI) ". This two-day event will feature keynote, plenary, and invited lectures by leading scientists and academics, alongside oral and poster presentations by students. The conference will focus on applied bioinformatics and various aspects of translational healthcare. DDTH 2025 aims to offer an exceptional platform for staying up-to-date with the latest research, fostering information exchange, and enabling networking opportunities among researchers. We warmly invite you to submit your posters and register for the conference.

Organizing Chairman/Secretaries;     Phone: [0000000000];     Email: ddthiitbhuvaranasi@gmail.com

Computer Aided Drug Design/Structure-Based Drug Designing, Biotechnology and Healthcare, Omics and Bioinformatics for healthcare, Protein targets and therapeutic proteins